Source: Journal of Cachexia, Sarcopenia and Muscle. Unidade: ICB
Subjects: MÚSCULO ESQUELÉTICO, HIPERGLICEMIA, QUIMIOTERAPIA, INSULINA, GLICOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA JUNIOR, Edson Alves de et al. Doxorubicin caused severe hyperglycaemia and insulin resistance, mediated by inhibition in AMPk signalling in skeletal muscle. Journal of Cachexia, Sarcopenia and Muscle, v. 7, n. 5, p. 615-625, 2016Tradução . . Disponível em: https://doi.org/10.1002/jcsm.12104. Acesso em: 09 out. 2024.APA
Lima Junior, E. A. de, Yamashita, A. S., Pimentel, G. D., Sousa, L. G. O. de, Santos, R. V. T. dos, Gonçalves, C. L., et al. (2016). Doxorubicin caused severe hyperglycaemia and insulin resistance, mediated by inhibition in AMPk signalling in skeletal muscle. Journal of Cachexia, Sarcopenia and Muscle, 7( 5), 615-625. doi:10.1002/jcsm.12104NLM
Lima Junior EA de, Yamashita AS, Pimentel GD, Sousa LGO de, Santos RVT dos, Gonçalves CL, Streck EL, Lira FS de, Rosa Neto JC. Doxorubicin caused severe hyperglycaemia and insulin resistance, mediated by inhibition in AMPk signalling in skeletal muscle [Internet]. Journal of Cachexia, Sarcopenia and Muscle. 2016 ; 7( 5): 615-625.[citado 2024 out. 09 ] Available from: https://doi.org/10.1002/jcsm.12104Vancouver
Lima Junior EA de, Yamashita AS, Pimentel GD, Sousa LGO de, Santos RVT dos, Gonçalves CL, Streck EL, Lira FS de, Rosa Neto JC. Doxorubicin caused severe hyperglycaemia and insulin resistance, mediated by inhibition in AMPk signalling in skeletal muscle [Internet]. Journal of Cachexia, Sarcopenia and Muscle. 2016 ; 7( 5): 615-625.[citado 2024 out. 09 ] Available from: https://doi.org/10.1002/jcsm.12104